ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      4,550.58
      (
      0.0%
      )
      US Tech 100
      15,650.00
      (
      0.37%
      )
      Dow Jones
      35,430.42
      (
      0.0%
      )
      Brent Oil
      84.045
      (
      1.66%
      )
      Bitcoin
      37,639.68
      (
      -0.61%
      )
      Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. GeoVax Labs Inc (GOVX)

      7. GeoVax Labs Inc (GOVX) News

      GOVX GeoVax Labs Inc

      0.43
      0.00 (0.0%)
      Pre Market
      Last Updated: 07:00:01
      Delayed by 15 minutes
      Company Name Stock Ticker Symbol Market Type
      GeoVax Labs Inc GOVX NASDAQ Common Stock
        Price Change Change Percent Stock Price Last Traded
      Upgrade Icon
      0.00 0.0% 0.43 07:00:01
      Open Price Low Price High Price Close Price Prev Close
      0.43
      more quote information »

      Recent News

      Date Time Source Heading
      11/29/202309:00GLOBEGeoVax to Participate in Upcoming December Investor Events
      11/28/202309:00GLOBEGeoVax COVID-19 Vaccine Clinical Data Presented at World..
      11/27/202316:06EDGAR2Form DEF 14A - Other definitive proxy statements
      11/17/202316:27EDGAR2Form PRE 14A - Other preliminary proxy statements
      11/14/202309:00GLOBEProgress on GeoVax’s Universal Coronavirus Vaccine..
      11/09/202312:40EDGAR2Form 8-K - Current report
      11/08/202316:04EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
      11/08/202316:03EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
      11/08/202316:01EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
      11/08/202316:00EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
      11/08/202316:00GLOBEGeoVax Reports Third Quarter 2023 Financial Results and..
      10/31/202309:00GLOBEGeoVax to Report Third Quarter 2023 Financial Results and..
      10/30/202309:00GLOBEGeoVax Commences Site Expansion for Phase 2 Trial of..
      10/25/202309:00GLOBEGeoVax to Participate in Upcoming November Investor and..
      10/24/202309:00GLOBEGeoVax Update: Clinical and Operational Progress Toward..
      10/09/202309:00GLOBEGeoVax Receives Notice of Allowance for Marburg Vaccine..
      10/05/202309:00GLOBEGeoVax Receives Notice of Allowance for HIV Vaccine Patent
      9/27/202316:33EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      9/27/202309:00GLOBEGeoVax to Participate in Upcoming October Investor and..
      9/26/202309:00GLOBEGeoVax Secures Multi-Product License for ProBioGen's..
      9/21/202309:35GLOBEDawson James Securities Announces October Date for 8th..
      9/20/202309:00GLOBEGeoVax Next-Generation COVID-19 Vaccine Data Presented at..
      9/19/202309:00GLOBEGeoVax Next-Generation COVID-19 Vaccine Demonstrates Potent..
      9/12/202309:00GLOBEGeoVax Presents Corporate Update at the H.C. Wainwright 25th..
      9/11/202309:00GLOBEGeoVax Completes Enrollment of Phase 2 Trial for..
      8/31/202309:00GLOBEGeoVax to Present at the H.C. Wainwright 25th Annual Global..
      8/28/202316:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      8/28/202309:00GLOBEGeoVax Receives Notice of Allowance for Malaria Vaccine..
      8/22/202316:06EDGAR2Form S-8 - Securities to be offered to employees in employee..
      8/21/202308:39EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      8/14/202316:53EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      8/14/202316:53EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      8/14/202316:52EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      8/14/202316:52EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      8/14/202316:51EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      8/14/202316:50EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      8/14/202316:50EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      8/14/202316:49EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      8/14/202316:48EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      8/14/202316:47EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      8/14/202316:46EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      8/10/202309:45EDGAR2Form 8-K - Current report
      8/10/202309:00GLOBEGeoVax Announces First Patients Vaccinated in Phase 2..
      8/09/202316:02EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
      8/09/202316:00GLOBEGeoVax Reports 2023 Second Quarter Financial Results and..
      8/02/202316:03EDGAR2Form 8-K - Current report
      7/26/202309:00GLOBEGeoVax to Report Second Quarter 2023 Financial Results and..
      7/24/202309:00GLOBEGeoVax Announces Issuance of Ebola Vaccine Patent
      7/20/202309:00GLOBEGeoVax Announces Initiation of Phase 2 Clinical Trial of..
      7/18/202316:27EDGAR2Form 8-K - Current report

      Your Recent History

      NASDAQ
      GOVX
      GeoVax Labs